NCT04521725

Brief Summary

Babies born very early (at less than 32 weeks) usually need help to breath right at birth, also called neonatal resuscitation. Healthcare providers (HCPs) are specially trained to provide this help. HCPs uses information about the baby's condition, such heart rate and oxygen levels, to decide whether they giving the baby effective help, or whether other actions are needed. It can be very stressful for even experienced HCPs to interpret all this data, coordinate a team, make decisions, and perform specialized skills all at the same time. More recently, new ways of monitoring how a baby is doing neonatal resuscitation has been studied. Respiratory function monitoring (RFM) is a machine that can measure how much air is going into the lungs. This is important as too much air can lead to lung damage, while too little air means that the baby isn't breathing effectively. Another measure is called cerebral near-infrared spectroscopy (cNIRS), which measures oxygen levels in the brain using a probe placed on the forehead. Providing the right amount of oxygen to the most vulnerable organ - the brain - can be important in lowering the risk for injuries to the brain such as brain bleeding. While these machines give us more information, it can also make it even harder for HCPs to focus on the task, adding more complexity to making decisions, adding to their workload, and causing more stress. To study the effect RFM and cNIRS may have on how affects HCPs workload and stress, the investigators will study HCPs self-reported workload during three time periods - first, doing resuscitations only using basic information (Group 1: heart rate, oxygen levels, direct observations of the baby), second, adding RFM (Group 2), finally adding both RFM and cNIRS (Group 3). A survey called NASA Task Load Index will be used to study HCPs workload. On a small number of teams, the investigators will also track where the leader of the team is looking using eye-tracking glasses, how stressed the leader is by measuring their heart rate, skin sweat, and pupil dilation. Finally, the investigators will collect some information about the baby's resuscitation and hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 20, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 5, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2021

Completed
Last Updated

January 13, 2023

Status Verified

January 1, 2023

Enrollment Period

1.1 years

First QC Date

August 18, 2020

Last Update Submit

January 11, 2023

Conditions

Keywords

Neonatal resuscitationHuman FactorsWorkloadRespiratory Function Monitoringcerebral near infrared spectroscopy

Outcome Measures

Primary Outcomes (1)

  • Team Leader's NASA Task Load Index (NASA-TLX) Mental Demand

    Team leader's subjective mental demand as reported by the NASA Task Load Index

    Immediately post resuscitation

Secondary Outcomes (10)

  • Composite team mental workload

    Immediately post resuscitation

  • Team Leader Visual Attention Distribution

    During resuscitation

  • Frequency of visual fixation to monitoring equipment Visual Access to each monitor display type (vital signs, RFM, NIRS)

    During resuscitation

  • Time to achieving target heart rate (HR) and oxygen saturation (SpO2)

    During resuscitation

  • Survival to 36 weeks

    36 weeks

  • +5 more secondary outcomes

Study Arms (3)

Group1: ECG+SpO2 only

NO INTERVENTION

Traditional ECG (heart rate) and SpO2 (pulse oximetry) monitoring for resuscitation only.

Group 2: ECG+SpO2+RFM

ACTIVE COMPARATOR

Addition of Respiratory Function Monitor to ECG and SpO2 during resuscitation.

Device: Respiratory Function Monitor (RFM)

Group 3: ECG+SpO2+RFM+NIRS

ACTIVE COMPARATOR

Addition of cerebral NIRS and Respiratory Function Monitor to ECG and SpO2 during resuscitation.

Device: Respiratory Function Monitor (RFM)Device: Cerebral Near-Infrared Spectroscopy (NIRS)

Interventions

Use of respiratory function monitor to detect tidal volume and expired CO2 to guide mask ventilation during neonatal resuscitation.

Group 2: ECG+SpO2+RFMGroup 3: ECG+SpO2+RFM+NIRS

Use of cerebral NIRS to determine cerebral oxygenation to guide oxygen titration during neonatal resuscitation.

Group 3: ECG+SpO2+RFM+NIRS

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • HCPs participating in resuscitations of very preterm infants (23+0-31+6 weeks) at the Royal Alexandra Hospital Neonatal Intensive Care Unit (NICU), a Level III NICU will be included.
  • Multiple gestations will be analyzed individually as separate resuscitations. HCPs will include different levels of experience and different disciplines (registered nurses, advance practice nurses, respiratory therapists, neonatal nurse practitioners, pediatric residents, neonatal fellows, clinical associates, and neonatal consultants).
  • All HCPs who participate in the resuscitation, regardless of role, will be eligible for completion of NASA-TLX surveys.
  • Participants who act as team leader will be eligible to be fitted with eye-tracking glasses to record their visual attention and Empatica E4 wristbands to measure physiological stress measurements.
  • For resuscitated infants, hospital outcomes will be included with parental consent.

You may not qualify if:

  • Teams involved in the resuscitation of infants born with congenital malformations, or involved in the care of infants for whom active resuscitation is not planned (i.e., comfort care only for periviable gestations) will be excluded.
  • Teams who do not consent to participate will also be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Alexandra Hospital

Edmonton, Alberta, Canada

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2020

First Posted

August 20, 2020

Study Start

October 5, 2020

Primary Completion

November 18, 2021

Study Completion

November 18, 2021

Last Updated

January 13, 2023

Record last verified: 2023-01

Locations